GGrantIndex
← Search

Clinical Protocol and Data Management

$16,666P30FY2018CANIH

University Of Arizona, Tucson AZ

Investigators

Linked publications, trials & patents

Paper 39631050Paper 39622842Paper 39612086Paper 39361227Paper 39312766Paper 39151774Paper 39100646Paper 39075233Paper 38875929Paper 38858600Paper 38826434Paper 38804255Paper 38769192Paper 38759377Paper 38729260Paper 38719743Paper 38715255Paper 38687603Paper 38658768Paper 38639990Paper 38613866Paper 38612480Paper 38474232Paper 38464045Paper 38453918Paper 38386696Paper 38386396Paper 38328594Paper 38313301Paper 38309054Paper 38291312Paper 38215755Paper 38203706Paper 38199366Paper 38164625Paper 38164604Paper 38097734Paper 38097593Paper 38096366Trial NCT07214506Trial NCT06009926Trial NCT05699603Trial NCT05237960Trial NCT05121051Trial NCT04530552Trial NCT03708055Trial NCT03602066Trial NCT03601507Trial NCT03578432Trial NCT03422536Trial NCT03402230Trial NCT03376971Trial NCT03365895Trial NCT03196180Trial NCT02581137Trial NCT02568566Trial NCT02348203Trial NCT02326805Trial NCT02123849Trial NCT01686165Trial NCT01433913Trial NCT01394211Trial NCT01385280Trial NCT01370889Trial NCT01288261Trial NCT01172028Trial NCT01097304Trial NCT01077453Trial NCT00980395Trial NCT00978718Trial NCT00900432Trial NCT00900341Trial NCT00898703Trial NCT00896935Trial NCT00892268Trial NCT00841204Trial NCT00752739Trial NCT00732498Trial NCT00721877Trial NCT00702299Trial NCT00701857Trial NCT00699907Trial NCT00619060Trial NCT00608634Trial NCT00601640Trial NCT00410618Trial NCT00373022Trial NCT00363805Trial NCT00303823Trial NCT00245024Trial NCT00091325Trial NCT00078897Trial NCT00003307Trial NCT00003082Patent 9486545Patent 9435812Patent 9415110Patent 9262824Patent 5650489Patent 5510240

Abstract

Project Summary / Abstract: Clinical Protocol and Data Management (CPDM) The Clinical Trials Office (CTO) at the University of Arizona Cancer Center (UACC) is the operational equivalent of the CPDM. It provides a centralized and comprehensive infrastructure for the conduct of clinical trials involving cancer patients. The CTO oversees institutional, externally peer-reviewed, National Clinical Trials Network (NCTN), and industry-sponsored studies. While treatment interventional trials are of major interest to the Cancer Center, the CTO also assists in the execution of trials with a broad range of other objectives, including diagnostics, cancer screening, basic science, health services, cancer prevention, and supportive care. The research supported by the CTO serves both adult and pediatric populations. The UACC has invested substantial support in the CTO to enable the management of important interventional trials, their associated accruals, and the increasing complexity of clinical trials. The CTO functions as a central administrative office for the implementation and conduct of internally and externally funded adult and pediatric oncology studies. Review and approval of protocols is performed by the Disease-Oriented Teams (DOTs) or Multidisciplinary Teams (MDTs), and the Scientific Review Committee and is required of UACC investigations prior to activation. There are nine designated DOTs and four that evaluate new protocols and monitor accrual for ongoing studies. The CTO also maintains and assures the quality of data regarding cancer clinical trial activation and accrual throughout the University. The CTO is led by well-qualified leadership and is subdivided into four major research support groups: 1) Review Committee and Regulatory Support Management; 2) Clinical Research Finance and Administrative Management; 3) Clinical Research, Data, and Biospecimen Management; and 4) Research Compliance / Quality Management. Clinical research support staff are positioned to effectively manage all processes of the trial lifecycle, and the CTO is organized in a manner that facilitates continuous improvement. The CTO has defined timelines for study activation that are important to maintain efficiency and effectiveness in conducting clinical research. The CTO maintains standard operating procedures (SOPs) and workflows that describe work processes conducted by the staff. The CTO facilitates the adoption of technology to increase operational efficiencies and quality management practices for supporting clinical research. The SOPs of the CTO stipulate that the CTO will conduct regularly scheduled internal reviews of protocol records. Since the last review period, the CTO expanded its capacity significantly to more appropriately oversee the trials currently open, and in preparation for a significant expansion of new faculty recruitment, the Phase I Program, and the community-based network of affiliate organizations. The UACC CTO adheres to the NIH policy that women and members of minority groups and their subpopulations be included in clinical research and supports increasing access to clinical research for children, consistent with the NIH recommendations. Data and safety monitoring support is provided for clinical trials.

View original record on NIH RePORTER →